The Valley Desk

NCT05643573 · Interventional trial

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Overall registry status Terminated

Phase 3

Conditions Atrial Fibrillation, Prevention of Stroke or Systemic Embolism

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov